Phase 3 Congenital Heart Disease Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
Effect of Sacubitril-Valsartan on Cardiac Structure and Function
Congenital Heart Disease
Mayo Clinic45 enrolled1 locationNCT06693674
Recruiting
Phase 3
NO During CPB in Neonates to Reduce Risk of AKI
SurgeryAKICHD - Congenital Heart Disease
Children's Hospital Medical Center, Cincinnati40 enrolled1 locationNCT04216927
Recruiting
Phase 2Phase 3
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
HypoxiaNeurodevelopmental DisordersCongenital Heart Disease in Children+1 more
University of Utah150 enrolled5 locationsNCT05767385
Recruiting
Phase 3
Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass
Congenital Heart Disease in ChildrenNeuroprotection
dr. M.J.N.L. Benders236 enrolled4 locationsNCT04217421